bioRxiv · 10.1101/2021.08.11.455827
Microphaser - a small-scale phasing approach for improved personalized neopeptidome creation
Abstract
MotivationHaplotype phasing approaches have been shown to improve accuracy of the search space of neoantigen prediction by determining if adjacent variants are located on the same chromosomal copy. However, the aneuploid nature of cancer cells as well as the admixture of different clones in tumor bulk sequencing data are challenging the current diploid based phasing algorithms. We present microphaser, a small-scale phasing approach to improve haplotyping variants in cancer samples. Microphaser aims to create a more accurate neopeptidome for downstream neoantigen prediction. ResultsMicrophaser achieves large concordance with state-of-the-art phasing-aware neoantigen prediction pipeline neoepiscope, with differences in edge cases and an improved filtering step. AvailabilityMicrophaser is written in the Rust programming language. It is made available via Github (https://github.com/koesterlab/microphaser)and Bioconda. The corresponding prediction pipeline (https://github.com/snakemake-workflows/dna-seq-neoantigen-prediction) has been written within the Snakemake workflow management system and can be deployed as part of the snakemake-workflows project.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Forster, J., Laehnemann, D., Paschen, A., Schramm, A., Schuler, M., Koester, J.. 2021-08-11. Microphaser - a small-scale phasing approach for improved personalized neopeptidome creation. https://doi.org/10.1101/2021.08.11.455827
Cite the original work for its findings. Save a collection to share your selection of sources.